CVS Caremark Corp


  • The Word on Dell, CVS & More Friday, 30 Mar 2007 | 5:15 PM ET

    The guys go behind the headlines and give you their take on... Dell's delay... CVS vs. Walgreen... and more. Find out where they see fast money.

  • Caremark Shareholders Approve CVS Acquisition Friday, 16 Mar 2007 | 11:47 AM ET

    Caremark Rx shareholders on Friday approved a roughly $24 billion takeover offer from drug-store chain CVS bringing to an end a months-long takeover fight with Express Scripts for the rival pharmacy benefits manager.

  • Celeb Tucker Holds Lead But Other Stars Heating Up!! Friday, 16 Mar 2007 | 10:58 AM ET

    Okay--here's our current celebrity standings as of the market close on Thursday, 3/15. Overall their approach is still a lot more conservative than the majority of our non-celeb leaders - more stable companies and purchases spread across multiple stocks, and it might end up being a race to see who can lose the least. But that's probably to be expected....

  • CVS Holders Approve Deal, But Caremark Vote Still Ahead Thursday, 15 Mar 2007 | 3:20 PM ET

    Shareholders of CVS, the No. 2 U.S. drugstore chain, approved the company's $23.9 billion plan to buy pharmacy benefits manager Caremark Rx.

  • Influential proxy advisory firm Institutional Shareholder Services said on Tuesday it recommends that Caremark Rx shareholders support a takeover proposal from drugstore chain CVS, reversing its previous stance.

  • In an exclusive interview with CNBC's David Faber, Express Scripts'  CEO George Paz said his nearly $27 billion bid for Caremark Rx is his "best and only" offer unless the rival pharmacy-benefits manager opens its financial records for review.

  • In an exclusive interview with CNBC's David Faber, CVS Chairman and Chief Executive Officer Tom Ryan said he won't raise his bid for Caremark.

  • Caremark Rx said on Friday a second request for information from U.S. antitrust regulators into a takeover offer from Express Scripts is evidence the bid from the rival pharmacy benefit manager may not be able to be completed.

  • CVS sweetened its $23.9 billion takeover bid for Caremark on Thursday with an increaseddividend, calling its newest proposal its "best and final" offer for the pharmacy-benefits manager.

  • Battle-Tested Buys Wednesday, 7 Mar 2007 | 6:10 PM ET

    Right now, the best move for investors is to find stocks that made it through the sell-off without a scratch. Luckily, Cramer’s here to help.

  • It's Time for the Lightning Round! Monday, 5 Mar 2007 | 7:02 PM ET

    Callers question Cramer about CVS, Medtronic, JPMorgan Chase and more...

  • Caremark Posts Higher Quarterly Profit, Revenue Wednesday, 21 Feb 2007 | 3:13 PM ET

    Pharmacy benefits manager and takeover target Caremark Rx on Tuesday reported higher earnings and net revenue for the fourth quarter, driven by an increase in retail and mail sales.

  • Caremark attorney Robert Thornton presented a document that he said showed that Express Scripts considered killing the CVS deal to be a successful outcome even if its own offer was rejected.

  • Caremark Vote Delayed After CVS Sweetens Takeover Bid Tuesday, 13 Feb 2007 | 4:51 PM ET

    A Delaware judge ordered Caremark Rx to delay a shareholder vote on a proposed acquisition by CVS just hours after the drugstore operator tripled the special cash dividend it proposes to pay as part of the deal.

  • Caremark Shareholder Adviser Opposes CVS Deal Monday, 12 Feb 2007 | 2:47 PM ET

    CtW said it would be urging Caremark shareholders, including the pension funds and investment managers, to vote against the deal.

  • Proxy advisory firm Glass Lewis said on Friday it recommended that shareholders of Caremark Rx  reject the planned $24 billion takeover by drug-store chain CVS.

  • The pharmacy benefits company reported a 32% increase in fourth-quarter earnings and raised its outlook for the first quarter.

  • CVS Profit Rises 3%, Outpacing Analysts' Estimates Thursday, 1 Feb 2007 | 10:44 AM ET

    The No. 2 U.S. drugstore chain posted a 3% increase in quarterly profit on Thursday, driven by strong sales of prescription medications and greater use of generic drugs, which are more profitable for pharmacies.

  • Eulogy for M&A's--Analysts Say No Funeral Yet Friday, 26 Jan 2007 | 3:00 PM ET

    R.I.P., M&A? Not according to two merger-watchers, who reassured "Power Lunch" viewers that corporate combinations are alive and well -- regardless of interest-rate fluctuation fears. Gerald Adolph, senior vice president at Booz, Allen Hamilton, told CNBC's Sue Herera that M&A doubters describe a twin-pronged nightmare....

  • Caremark Urges Shareholders to Vote for CVS Deal Tuesday, 23 Jan 2007 | 9:50 AM ET

    Caremark Rx said on Tuesday it sent a letter urging its shareholders to support the $24 billion acquisition by drug-store retail chain CVS  and reject a $25 billion hostile takeoveroffer from Express Scripts.